Aehr Test Systems falls as tariff concerns delay guidance reinstatement (AEHR:NASDAQ)

Core Viewpoint - Aehr Test Systems experienced a nearly 14% decline in shares during premarket trading due to the decision not to reinstate formal guidance, attributing this to uncertainties related to tariffs [1] Financial Performance - The company reported fiscal first-quarter revenue of $11 million, which represents a 16% decrease year-over-year from $13.1 million [1]